Clinical Trial Update: BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating blisibimod added to methotrexate for induction of remission in ANCA-associated small vessel vasculitis (granulomatosis with polyangii…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granulomatosis with Polyangiitis
• Microscopic Polyangiitis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• blisibimod (blisibimod)

Snippet

Sponsor: Anthera Pharmaceuticals | Conditions: Granulomatosis With Polyangiitis, Microscopic Polyangiitis | Phase 2 | Status: WITHDRAWN